Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Chemical Sciences named after A.B. Bekturov is a leading research organization in Kazakhstan focused on the development of novel pharmaceutical agents and advanced chemical materials. Established in 1945, the institute specializes in the synthesis of bioactive heterocyclic compounds and the creation of innovative polymer-based drug delivery systems. Its most notable achievements include the development and commercialization of original local anesthetics such as Richlokain and Kazcain. The institute also conducts extensive research into anti-tuberculosis and anti-cancer treatments, leveraging its expertise in organic and polymer chemistry. Operating under the Satbayev University, it serves as a critical hub for chemical R&D and industrial innovation in the Central Asian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Chemical Sciences named after A.B. Bekturov.